This activation promotes the release of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β, ultimately exacerbating non-alcoholic fatty liver disease (NAFLD) [22,23]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.